e-learning
resources
Virtual 2021
05.09.2021
Pathogenesis and pathophysiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic findings in a family with hereditary spherocytosis, haemolytic anaemia and pulmonary hypertension
M. Shaukat (Heidelberg, Germany), M. Lankeit (Berlin, Germany), D. Cao (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), E. Grünig (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany)
Source:
Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session:
Pathogenesis and pathophysiology of pulmonary hypertension
Session type:
E-poster
Number:
596
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Shaukat (Heidelberg, Germany), M. Lankeit (Berlin, Germany), D. Cao (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), E. Grünig (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany). Genetic findings in a family with hereditary spherocytosis, haemolytic anaemia and pulmonary hypertension. 596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Related content which might interest you:
Should we screen for hereditary pulmonary hypertension?
Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life
Year: 2020
Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020
Year: 2021
Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
Source: Eur Respir J 2004; 23: 373-377
Year: 2004
Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome
Source: Eur Respir J 2003 Oct 01;22(4):709-711
Year: 2003
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult
Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019
Year: 2020
A rare diagnosis: Hermansky-Pudlak syndrome in a patient with pulmonary fibrosis, oculocutaneous albinism and thrombocytopathy
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia
Source: Eur Respir J 2009; 33: 1186-1194
Year: 2009
High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Genetic epidemiology of hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformation
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Autoimmune polyglandular syndrome and pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 657
Year: 2006
Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Iron deficiency is common in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 1386-1391
Year: 2011
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
Source: Eur Respir J 2013; 42: 1271-1282
Year: 2013
Inherited thrombophilia in the development of thrombotic conditions in patients with COPD
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept